Linc

Linc Operating Expenses

The Total Operating Expenses of Linc (LINC.ST) as of Nov 20, 2026 is 182.34 SEK. In the previous year, Total Operating Expenses was 3.74 M SEK — a change of -100.00% (lower).

Operating Expenses

182.34SEK

YoY

-100.00%

Last updated:

Total Operating Expenses of Linc is 2023 182.34 SEK. Total Operating Expenses of Linc was 2022 3.74 M SEK. It decreases by -100.00% lower compared to the previous year.

The Linc Operating Expenses history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Operating Expenses
Date
Operating Expenses
Jan 1, 2018
1.08 M SEK
Jan 1, 2019
573,130.10 SEK
Jan 1, 2020
1.86 M SEK
Jan 1, 2021
10.75 M SEK
Jan 1, 2022
3.74 M SEK
Jan 1, 2023
182.34 SEK
The Linc Operating Expenses history
YEAROperating ExpensesYoY
182.34SEK-100.00%
3.74 MSEK-65.20%
10.75 MSEK+477.15%
1.86 MSEK+224.84%
573,130.10SEK-47.13%
1.08 MSEK—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Linc Stock analysis

What does Linc do? Linc AB generates revenue through long-term share ownership in Nordic life science companies, focusing on pharmaceutical and medical technology sectors. The company invests in both private and public firms, including early-stage drug development and operational medical technology companies. Linc Invest actively supports portfolio companies by collaborating with management, founders, and boards to unlock growth potential and drive expansion. Its industrial network enables strategic participation in nomination committees and development planning. The firm targets Nordic life science product-oriented companies, prioritizing pharmaceuticals and medical technology. Investments span research and operational phases, with drug development typically occurring earlier than in medical technology. Linc AB maintains a hands-on approach as a long-term owner, leveraging its network to assist portfolio companies in achieving ambitious development goals. Linc AB's business model centers on active ownership and strategic partnerships within the Nordic life science ecosystem. It focuses on companies with strong product pipelines, particularly in pharmaceuticals, where investments often occur during initial development stages. The company's role as a supportive shareholder drives value creation through collaborative governance and targeted expansion strategies. Linc is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Linc stock

Total Operating Expenses of Linc is 182.34 SEK in 2023.

Total Operating Expenses of Linc changed from 3.74 M SEK to 182.34 SEK, representing a -100.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Total Operating Expenses Linc since 2006 – with annual values, charts, and detailed analysis.

Operating expenses are the costs incurred in the normal course of business operations, including COGS, SG&A, R&D, and depreciation.

Total Operating Expenses's SEK is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Total Operating Expenses's Linc historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Linc

All Key Metrics — Linc